Malakul, Wachirawadee

Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta. [electronic resource] - Clinical and experimental pharmacology & physiology Feb 2008 - 192-200 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1440-1681

10.1111/j.1440-1681.2007.04811.x doi


Acetylcholine--pharmacology
Animals
Aorta, Thoracic--drug effects
Apamin--pharmacology
Biological Factors--metabolism
Blood Glucose--metabolism
Body Weight
Charybdotoxin--pharmacology
Cholesterol--blood
Cyclooxygenase Inhibitors--pharmacology
Diabetes Mellitus, Experimental--metabolism
Diabetes Mellitus, Type 1--metabolism
Disease Models, Animal
Dose-Response Relationship, Drug
Enzyme Inhibitors--pharmacology
Guanylate Cyclase--antagonists & inhibitors
Hypercholesterolemia--metabolism
Indomethacin--pharmacology
Male
Nitric Oxide--metabolism
Nitric Oxide Synthase--antagonists & inhibitors
Nitroarginine--pharmacology
Nitroprusside--pharmacology
Oxadiazoles--pharmacology
Oxidative Stress
Potassium Channel Blockers--pharmacology
Potassium Channels, Calcium-Activated--antagonists & inhibitors
Quinoxalines--pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors
Soluble Guanylyl Cyclase
Superoxides--metabolism
Vasodilation--drug effects
Vasodilator Agents--pharmacology